期刊文献+

广东汉族79例中iKIR及其HLA配体表达的初步分析 被引量:1

Inhibitory KIR and its HLA ligand identified in Guangdong Han population
原文传递
导出
摘要 目的 探索杀伤细胞免疫球蛋白样抑制性受体 (iKIR)及其人白细胞抗原 (HLA)配体在中国广东汉族人群中的分布。方法 对 79例广东汉族人 ,采用引物序列特异性扩增法检测其iKIR表型 ,HLA A、B、Cw表型。HLA A、B分型采用BiotestHLA分型 (SSP)试剂盒 ,HLA C分型采用半量全自动PCR SSO分型。结果 KIR2DL1、2DL2、2DL3、2DL4、2DL5、3DL1、3DL2、3DL3的表型频率分别为0 .87、0 .13、0 .5 2、1、0 .18、0 .94、1和 0 .99。个体 86 .1%表达 1种以上iKIR HLA配对 ,其中 3DL1 HLA Bw4配对表型频率为 6 9.6 % ,2DL2 C2为 4 3.0 % ,2DL1 C1为 16 .5 %。由于不表达HLA A3,该组人群中无 3DL2 HLA A3受体配体对。 13.9%人群缺乏iKIR HLA配对。结论 约 7/ 8的广东汉族个体表达1种以上iKIR HLA配对 ,以 3DL1 HLA Bw4配对为主 ;约 1/ 8个体缺乏已知的iKIR HLA配对。 Objective To investigate the expression of inhib it ory killer immunoglobulin-like receptor(iKIR) and its ligand in Chinese people. Methods Seventy-nine cases of Guangdong Han bone marrow donors were studied. iKIR was typed by sequence specific polymerase chain react ion, HLA-A and B was typed by Biotest HLA typing kit, HLA-Cw was typed by Dyna l typing kit. Results Expression frequency of KIR2DL1, 2D L2, 2DL3, 2DL4, 2DL5, 3DL1, 3DL2, 3DL3 is 0.87, 0.13, 0.52, 1, 0.18, 0.94, 1 and 0.99 respectively. 86.1% cases have more than one kind of iKIR-HLA ligand combination. Expression frequency of 3DL1-HLA-Bw4 combination is 69.6%, and 2D L2-C2 and 2DL1-C1 is 43.0%, 16.5% respectively. No 3DL2-HLA-A3 combination i s found due to the lack of HLA-A3 in this group and 13.9% cases have no iKIR-H LA ligand combination. Conclusion About seven/eighth Guan gdong Han people have more than one iKIR-HLA combination, with 3DL1-HLA-Bw4 a s the most common one. About one/eighth cases do not have any known iKIR-HLA co mbination. [
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2004年第9期679-681,共3页 Chinese Journal of Microbiology and Immunology
关键词 KIR DL HLA-A 表达 表型 配体 人群 广东汉族人 配对 缺乏 Inhibitory killer immunoglobulin-like receptor HLA Guangdong Han population
  • 相关文献

参考文献9

  • 1Hsu KC, Liu XR, Selvakumar A, et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol, 2002, 169: 5118-5129. 被引量:1
  • 2Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity, 1997, 7: 753-763. 被引量:1
  • 3Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol, 2002, 20: 217-251. 被引量:1
  • 4Dohring C, Scheidegger D, Cella M, et al. Human killer inhibitory receptor specific for HLA-A. J Immunol, 1996, 156: 3098-3101. 被引量:1
  • 5Henry CH, Nikaein A, Wolford LM. Analysis of human leukocyte antigens in patients with internal derangement of the temporomandibular joint. J Oral Maxillofac Surg, 2002, 60: 778-783. 被引量:1
  • 6Rajalingam R, Krausa P, Shilling HG, et al. Distinctive KIR and HLA diversity in a panel of north Indian Hindus. Immunogen, 2002, 53: 1009-1019. 被引量:1
  • 7Toneva M, Lepage V, Lafay G, et al. Genomic diversity of natural killer cell receptor genes in three population. Tissue Antigen, 2001, 57: 358-362. 被引量:1
  • 8Lopez-Botet M, Llano M, Navarro F, et al. NK cell recognition of non-classical HLA class I molecules. Semin Immunol, 2000, 12: 109-119. 被引量:1
  • 9Pridgeon C, Lennon GP, Pazmany L, Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56 bright, CD94 bright, CD158 negative phenotype. Rheumatology (Oxford), 2003, 42: 870-878. 被引量:1

同被引文献13

  • 1Hsu KC,Keever-Talor CA,Wilton A,et al.Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.Blood,2005,105:4878-4884. 被引量:1
  • 2Cook MA,Milligan DW,Fegan CD,et al.The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia.Blood,2004,103:1521-1526. 被引量:1
  • 3Shilling HG,McQueen KL,Cheng NW,et al.Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.Blood,2003,101:3730-3740. 被引量:1
  • 4Shlomchik WD,Couzens MS,Tang CB,et al,Prevention of graft versus host disease by inactivation of host antigen-presenting cells.Science,1999,285:412-415. 被引量:1
  • 5Schaffer M,Malmberg KJ,Ringden O,et al.Increased infectionrelated mortality in KIR ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation.Transplantation,2004,78:1081-1085. 被引量:1
  • 6Boyington JC,Motyka SA,Schuck P,et al.Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class ⅠMHC ligand.Nature,2000,405:537-543. 被引量:1
  • 7Boyington JC,Brooks AG,Sun PD.Structure of killer cell immunoglobulin-like receptors and their recognition of class Ⅰ MHC molecules.Immunol Rev,2001,181:66-78. 被引量:1
  • 8Biassoni R,Cantoni C,Falco M,et al.The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.J Exp Med,1996,183:645-650. 被引量:1
  • 9Uhrberg M,Valiante NM,Shum BP,et al.Human diversity in killer cell inhibitory receptor genes.Immunity,1997,7:753-763. 被引量:1
  • 10Litwin V,Gumperz J,Parham P,et al.NKB1:a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.J Exp Med,1994,180:537-543. 被引量:1

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部